Denis M. Daigle, Ph.D.
Affiliations: | 2003 | McMaster University, Hamilton, ON, Canada |
Area:
Antibiotic resistance; chemically synthesizing antibioticsGoogle:
"Denis Daigle"Mean distance: 8.51 | S | N | B | C | P |
Parents
Sign in to add mentorGerard D. Wright | grad student | 2003 | McMaster University | |
(Characterization of AAC(6')-APH(2''), a bifunctional aminoglycoside modifying enzyme.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Karlowsky JA, Hackel MA, Wise MG, et al. (2022) Activity of Cefepime-Taniborbactam and Comparators against Clinical Isolates of Gram-Negative Bacilli from 2018 to 2020: Results from the Global Evaluation of Antimicrobial Resistance via Surveillance (GEARS) Program. Antimicrobial Agents and Chemotherapy. e0128122 |
Roach EJ, Uehara T, Daigle DM, et al. (2021) The Next-Generation β-Lactamase Inhibitor Taniborbactam Restores the Morphological Effects of Cefepime in KPC-Producing Escherichia coli. Microbiology Spectrum. e0091821 |
Trout RE, Zulli A, Mesaros E, et al. (2021) Discovery of VNRX-7145 (VNRX-5236 Etzadroxil): An Orally Bioavailable β-Lactamase Inhibitor for Enterobacterales Expressing Ambler Class A, C, and D Enzymes. Journal of Medicinal Chemistry |
Chatwin CL, Hamrick JC, Trout REL, et al. (2021) Microbiological characterization of VNRX-5236: a broad spectrum β-lactamase inhibitor for rescue of the orally bioavailable cephalosporin ceftibuten as a carbapenem-sparing agent against strains of Enterobacterales expressing extended spectrum β-lactamases and serine carbapenemases. Antimicrobial Agents and Chemotherapy |
Hamrick JC, Docquier JD, Uehara T, et al. (2019) VNRX-5133 (Taniborbactam), a broad-spectrum inhibitor of serine- and metallo-β-lactamases, restores activity of cefepime in and . Antimicrobial Agents and Chemotherapy |
Liu B, Trout REL, Chu GH, et al. (2019) Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-Lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections. Journal of Medicinal Chemistry |
Daigle D, Vernacchio S, Xerri L, et al. (2018) 1395. Defining the Magnitude of AUC:MIC Driver for Efficacy of the β-Lactamase Inhibitor VNRX-5133 When Combined with Cefepime Against KPC- and VIM/NDM-Producing Enterobacteriaceae and P. aeruginosa Open Forum Infectious Diseases. 5: S429-S429 |
Daigle D, Hamrick J, Chatwin C, et al. (2018) 1370. Cefepime/VNRX-5133 Broad-Spectrum Activity Is Maintained Against Emerging KPC- and PDC-Variants in Multidrug-Resistant K. pneumoniae and P. aeruginosa Open Forum Infectious Diseases. 5: S419-S420 |
Fetar H, Gilmour C, Klinoski R, et al. (2011) mexEF-oprN multidrug efflux operon of Pseudomonas aeruginosa: regulation by the MexT activator in response to nitrosative stress and chloramphenicol. Antimicrobial Agents and Chemotherapy. 55: 508-14 |
Caughlan RE, Sriram S, Daigle DM, et al. (2009) Fmt bypass in Pseudomonas aeruginosa causes induction of MexXY efflux pump expression. Antimicrobial Agents and Chemotherapy. 53: 5015-21 |